Journal ArticleDOI
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
Reads0
Chats0
About:
This article is published in European Heart Journal.The article was published on 1994-10-01. It has received 1177 citations till now. The article focuses on the topics: Framingham Risk Score.read more
Citations
More filters
Journal ArticleDOI
Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy.
Mirko Di Martino,Luca Degli Esposti,Pierfrancesco Ruffo,Silvia Bustacchini,Alessandro Catte,Alessandra Sturani,Ezio Degli Esposti +6 more
TL;DR: Analyzing the data contained in the general medicine database made it possible to evaluate the use of LLDs in clinical practice and to establish the need to pay greater attention to achieving the objective set by the treatment.
Journal ArticleDOI
Cardiac rehabilitation into thenew millennium
TL;DR: The failure of current cardiac teaching programmes to elicit behavioural changes may be due to lack of individualized approach, and inappropriate timing of information, and programmes often have not been structured to suit patients' individual needs.
Journal ArticleDOI
STATT: A titrate-to-goal study of Simvastatin in Asian patients with coronary heart disease
Namsik Chung,Seung Yun Cho,Donghoon Choi,Jun Ren Zhu,Kathy Lai-Fun Lee,Pui Yin Lee,Sang Hoon Lee,Sahng Lee,Jiann Jong Wang,Wei Hsien Yin,Mason Shing Young,Kwang Kon Koh,Ji Won Son,Somkiat Sangwatanaroj,Pradit Panchavinnin,Rewat Phankingthongkum,Nai Sheng Cai,Wei Fu Fan +17 more
TL;DR: Simvastatin was effective and well tolerated at doses of 20, 40, and 80 mg/d in Asian patients with coronary heart disease and Titration enabled the majority to achieve target LDL-C levels of < or = 100 mg/dL.
Journal ArticleDOI
Estado actual de los programas de prevención secundaria y rehabilitación cardíaca en España
TL;DR: It is known that all cardiac patients benefit from these programs, especially older patients, and the usefulness of these programs has been fully demonstrated in numerous studies involving patients with ischemic heart disease and more recently in chronic heart failure and heart transplantation patients.
Journal ArticleDOI
Suboptimal choices and dosing of statins at start of therapy.
Aukje K. Mantel-Teeuwisse,Olaf H. Klungel,Tom Schalekamp,W. M. Monique Verschuren,Arijan J. Porsius,Anthonius de Boer +5 more
TL;DR: The coadministration of potentially interacting drugs may have led to a change in statin choice, but not in dosage lowering, and the findings suggest that the quality of statin therapy could be improved.
Related Papers (5)
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more